Incorporate the Given Market Name Growth Accelerated by Advancements in Drug Therapy

 

Gout Disease Treatment 

Gout disease is a form of inflammatory arthritis caused due to buildup of uric acid crystals in the joints, resulting in sudden attacks of painful arthritis. Treatments for gout aim to reduce inflammation, prevent attacks, and lower uric acid levels in the blood. Advancements in drug therapy for gout such as introduction of interleukin-1 inhibitors, uricosuric drugs, and xanthine oxidase inhibitors have accelerated the growth of gout disease treatment market. The global gout disease treatment market is estimated to be valued at US$ 3.01 Bn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Introduction of interleukin-1 inhibitors such as canakinumab and rilonacept for the management of gout attacks has boosted the growth of the gout disease treatment market. These drugs directly block interleukin-1, a pro-inflammatory cytokine involved in acute gout attacks, and help provide faster relief from intense gout flares compared to conventional treatments. Additionally, development of novel uricosuric drugs such as lesinurad in combination with xanthine oxidase inhibitors help lower serum uric acid levels more effectively for long-term management of chronic gout. Advancements in drug therapy have improved treatment outcomes and quality of life of gout patients, thereby driving increased adoption of gout disease therapeutics.
Segment Analysis

The global Gout Disease Treatment market is segmented into drug class and geography. By drug class, the market is further divided into Xanthine Oxidase Inhibitors, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Biosimilars, and others. Xanthine Oxidase Inhibitors dominates the market currently with a market share of over 35% due to its high efficacy in inhibiting uric acid production, the root cause of gout.

Key Takeaways

The global Gout Disease Treatment market is expected to witness high growth. Regional analysis North America accounts for the largest market share of over 45% due to increasing prevalence of gout and rising healthcare spending in the region. Europe and Asia Pacific regions are also growing at a significant rate due to rapid urbanization and changing lifestyle in countries like India and China.

Key players operating in the Gout Disease Treatment market are Kerry Group plc, Takasago International Corporation, Sensient Technologies Corporation, Symrise AG, Givaudan SA, Firmenich International SA, Frutarom Industries Ltd., Citromax Flavors, Inc., and International Flavors & Fragrances Inc. Kerry Group plc dominates the market with a market share of over 20% and is investing significantly in research and development of innovative products.

North America accounts for the largest market share of over 45% due to increasing prevalence of gout and rising healthcare spending in the region. Europe is the second largest market for gout disease treatment with a share of over 30% due to better reimbursement policies. Asia Pacific is expected to witness highest growth during the forecast period expanding at a CAGR of 11.5% with countries like China and India emerging as major markets. This is owing to rising disposable incomes, growing awareness about treatment, and improving healthcare infrastructure in emerging Asian countries.

Key players operating in the Gout Disease Treatment market share are Kerry Group plc, Takasago International Corporation, Sensient Technologies Corporation, Symrise AG, Givaudan SA, Firmenich International SA, Frutarom Industries Ltd., Citromax Flavors, Inc., and International Flavors & Fragrances Inc. Kerry Group plc is one of the market leaders with a market share of over 20% and focuses on enhancing their drug portfolio for gout through strategic collaborations and acquisitions. Takasago International Corporation, produces natural and nature-identical flavoring ingredients, is investing significantly in gout drug research and development.

 

 Get more insights on this topic https://www.newswirestats.com/gout-disease-treatment-market-industry-insights-trendsgout-disease-treatment-market-2023-2030/

Comments

Post a Comment

Popular posts from this blog

Increasing aircrafts deliveries to fuel the growth of Aircraft Radome Market

Image
Aircraft Radome Market The global  Aircraft Radome Market is estimated to be valued at US$ 640.7 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Radome is a structural, weatherproof enclosure that protects a radar system or antenna and is transparent to electromagnetic waves. Radomes allow radar systems and antennas to function effectively while protecting them from harsh environmental conditions. In aircrafts, radomes provide structural integrity, aircraft aerodynamic compatibility and protection from heat, wind, and other extreme weather conditions of flight. They are made from advanced composite materials like fiberglass, graphite-epoxy, and thermoplastics. Aircraft radomes have applications in both military as well as commercial aircrafts across a wide range of aircraft platforms. Market key trends: One of the major trends in the b is the growin
Read more

The Global Naloxone Market Is Set To Experience Exponential Growth Owing To Rising Opioid Overdoses

Image
   naloxone market The naloxone market has experienced significant growth in recent years owing to increasing cases of opioid overdoses across the globe. Naloxone is an opioid antagonist medication used to reverse the effects of opioid overdoses including life-threatening depression of central nervous system and respiratory functions. The global naloxone market is estimated to be valued at US$ 1,422.26 million in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period of 2024-2030. Naloxone is administered as an injection into a muscle or vein or as a nasal spray. It is effective against both natural and synthetic opioids such as morphine, heroin, oxycodone, fentanyl, and methadone. Rising abuse and misuse of prescription opioids and increasing societal acceptability of opioids for pain management have been identified as major causes of opioid epidemics in many countries. Moreover, governmental support through policy and funding initiatives for wider public access a
Read more

Feminine Hygiene Products Market Growth Accelerated By Rising Awareness About Women Hygiene

Image
Feminine Hygiene Products Market    Feminine hygiene products provide effective solutions for maintaining women's intimate hygiene and offer convenience during menstrual cycles. Sanitary pads, tampons, panty liners, and menstrual cups are commonly used feminine hygiene products that efficiently absorb menstrual blood flow. The growing awareness about women's hygiene and health and availability of innovative product varieties catering to different needs have accelerated the demand for these products. Factors such as changing lifestyles and rising incomes have further contributed to the increased spending on intimate healthcare needs of women. The global Feminine Hygiene Products Market is estimated to be valued at US$ 41.71 Bn in 2024 and is expected to exhibit a CAGR of 23.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth in the feminine hygiene products
Read more